KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Accumulated Expenses (2019 - 2025)

Historic Accumulated Expenses for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $143.4 million.

  • GoodRx Holdings' Accumulated Expenses rose 5470.07% to $143.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $143.4 million, marking a year-over-year increase of 5470.07%. This contributed to the annual value of $99.1 million for FY2024, which is 3897.57% up from last year.
  • According to the latest figures from Q3 2025, GoodRx Holdings' Accumulated Expenses is $143.4 million, which was up 5470.07% from $95.7 million recorded in Q2 2025.
  • GoodRx Holdings' 5-year Accumulated Expenses high stood at $143.4 million for Q3 2025, and its period low was $33.8 million during Q2 2021.
  • For the 5-year period, GoodRx Holdings' Accumulated Expenses averaged around $66.6 million, with its median value being $66.0 million (2023).
  • Its Accumulated Expenses has fluctuated over the past 5 years, first plummeted by 632.54% in 2022, then surged by 5470.07% in 2025.
  • Quarter analysis of 5 years shows GoodRx Holdings' Accumulated Expenses stood at $50.7 million in 2021, then decreased by 6.33% to $47.5 million in 2022, then surged by 50.09% to $71.3 million in 2023, then soared by 38.98% to $99.1 million in 2024, then skyrocketed by 44.63% to $143.4 million in 2025.
  • Its last three reported values are $143.4 million in Q3 2025, $95.7 million for Q2 2025, and $77.6 million during Q1 2025.